“…From this study, we deduce that an FcRn-targeted HIV subunit vaccine delivers soluble antigens to mucosal DCs and gives rise to long-lived T cell help for antibody responses (5,25,46). FcRn-targeted mucosal immunizations may be further benefited by an additional function for FcRn in antigen presentation (29,32,40). Additional studies are required to study memory and secondary responses after the targeted delivery of antigens to DCs via FcRn-mediated transport.…”